发明名称 |
Agent for Eliminating Multidrug Resistance |
摘要 |
The invention belongs to medicine, namely to pharmacology, and may be used to overcome multiple drug resistance in oncological and infectious patients undergoing long-term chemotherapy. Essence of the invention: proposed herein as a therapeutic agent intended to overcome multiple drug resistance is a hexapeptide with the following structural formula: lysyl-histidyl-glycyl-lysyl-histidyl-glycine. |
申请公布号 |
US2016022762(A1) |
申请公布日期 |
2016.01.28 |
申请号 |
US201514853529 |
申请日期 |
2015.09.14 |
申请人 |
LEBEDEV Vasiliy V. |
发明人 |
LEBEDEV Vasiliy V. |
分类号 |
A61K38/08;A61K45/06;A61K9/02;A61K9/00;A61K9/08 |
主分类号 |
A61K38/08 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for preventing or treating multiple drug resistance in a patient comprising administering an effective amount of a therapeutic agent comprising a hexapeptide with the following structural formula: lysyl-histidyl-glycyl-lysyl-histidyl-glycine (SEQ ID NO: 1) and a target additive prior to and during chemoradiotherapy. |
地址 |
Moscow RU |